Literature DB >> 25198824

Donor artery aneurysm formation following the ligation of haemodialysis arteriovenous fistula: a systematic review and case reports.

Ali Kordzadeh1, Raquel M D'Espiney Barbara, Ali S Ahmad, Muhammad A Hanif, Yiannis P Panayiotopoulos.   

Abstract

PURPOSE: The purpose of this study is to investigate the pathogenesis, presentation and diagnosis of donor artery aneurysm formation following arteriovenous fistula (AVF) ligation and reach a consensus on their management.
METHODS: A systematic review of literature in Ovid, MedLine, Embase, Scopus and CINHAL in the English language from 1951 to 2014 was performed. This was accompanied by two case reports. A total of 12 articles with 23 case reports were identified. Variables including patient's demographics, signs, symptoms, fistula type, duration of fistula use, time to aneurysm formation, renal transplantation, diagnostic modality, aneurysm type and size, type of surgery and outcome were reviewed.
RESULTS: The data demonstrate a male predominance (5:1) and a median age of 47 years (range, 27-75 years). The median duration of access was 54 months (range, 6-300 months). The median time from ligation to aneurysm was 120 months (range, 6-280 months). The commonest aneurysm was of the brachial artery (BA, n = 21, 84%). The commonest type of AVF was radiocephalic (n = 15, 60%) followed by brachiocephalic AVF (n = 9, 36%). The management of choice was aneurysmectomy followed by interposition vein grafting (n = 12, 50%) with a median reported patency of 12 months (range, 1-38 months). This was followed by polytetrafluoroethylene (PTFE) grafting (n = 6, 25%) with a median reported patency of 6 months (range, 1-48 months).
CONCLUSIONS: The pathogenesis of donor artery aneurysms remains contentious. This review suggests that duplex is the investigative modality of choice and aneurysmectomy with interposition grafting is preferred over bypass.

Entities:  

Mesh:

Year:  2014        PMID: 25198824     DOI: 10.5301/jva.5000297

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  7 in total

1.  Aneurysmal Degeneration of the Brachial Artery after Vascular Access Creation: Surgical Treatment Results.

Authors:  Sérgio Teixeira; Pedro Sá Pinto; Carlos Veiga; Ivone Silva; Rui Almeida
Journal:  Int J Angiol       Date:  2017-04-11

2.  A dual-plane approach for surgical treatment of pseudoaneurysm with arteriovenous fistula in hemodialysis patients.

Authors:  Ji Min Kim; Min Sung Tak; Jin Seok Kang; Chul Moon
Journal:  Arch Plast Surg       Date:  2021-05-15

3.  Giant true Brachial Artery Aneurysm after Hemodialysis Fistula Closure in a Renal Transplant Patient.

Authors:  Doriana Ferrara; Michele Di Filippo; Flavia Spalla; Anna Maria Giribono; Emanuela Viviani; Annamaria Santagata; Umberto Bracale; Michele Santangelo; Luca Del Guercio; Umberto Marcello Bracale
Journal:  Case Rep Nephrol Dial       Date:  2016-11-01

4.  Giant Brachial Aneurysm after Arteriovenous Fistula Ligation: A Review of the Different Surgical Approaches.

Authors:  Alessia Salerno; Marco Leopardi; Annamaria Maggipinto; Marco Ventura
Journal:  Case Rep Nephrol Dial       Date:  2020-05-27

5.  Surgical intervention for upper extremity nerve compression related to arteriovenous hemodialysis accesses.

Authors:  Jan Hm Tordoir; Magda M van Loon; Niek Zonnebeld; Maarten Snoeijs; Ferry van Nie
Journal:  J Vasc Access       Date:  2020-05-21       Impact factor: 2.283

6.  Recanalization of thrombosed aneurysmal hemodialysis arterovenous fistulas using a hybrid technique based on data from a single center.

Authors:  Wei Liu; Meng Wu; Xu Wang; Xiao-Kang Huang; Wen-Jiao Cai; Teng-Yun Ding; Liang-Liang Duan; Rui Qiao; Yong-Gui Wu
Journal:  BMC Nephrol       Date:  2022-05-14       Impact factor: 2.388

7.  True Brachial Artery Aneurysm in Patients with Previous Arterio-Venous Fistula Ligation and Immunosuppressant Therapy for Renal Transplantation: Case Report and Literature Review.

Authors:  Sorin Barac; Andreea Luciana Rata; Alexandra Ioana Popescu; Roxana Ramona Onofrei; Sorin Dan Chiriac
Journal:  Healthcare (Basel)       Date:  2022-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.